Brain metastases from solid tumors: Disease outcome according to type of treatment and therapeutic resources of the treating center

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Fabi, Alessandra ^a   Felici, Alessandra ^a   Metro, Giulio ^a   Mirri, Alessandra ^a   Bria, Emilio ^a   Telera, Stefano ^a   Moscetti, Luca ^b   Russillo, Michelangelo ^a   Lanzetta, Gaetano ^c   Mansueto, Giovanni ^d   Pace, Andrea ^a   Maschio, Marta ^a   Vidiri, Antonello ^a   Sperduti, Isabella ^a   Cognetti, Francesco ^a   Carapella, Carmine M ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b BELCOLLE HOSPITAL   (Italy)

^c INI   (Italy)

^d Umberto i Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COBALT THERAPY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEALTH SURVEY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; SOLID TUMOR; STEREOTACTIC RADIOSURGERY; SURVIVAL TIME; WHOLE BRAIN RADIOTHERAPY; BRAIN TUMOR; CANCER CENTER; CLINICAL TRIAL; HEALTH CARE SURVEY; KAPLAN MEIER METHOD; METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HEALTH CARE SURVEYS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONCOLOGY SERVICE, HOSPITAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78651440131     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-10     Document Type: Article

References (23)

1. Demographics of brain metastases. JD Johnson B Young, Clin N Am 1996 7 337 344
2. Metastatic brain tumors. R Sawaya RK Bindal FF Lang D Abi-Said, Brain tumors. An encyclopedic approach London: Kaye AH and Laws Jr ER, Churchill Livingstone, 2 2001 999 1026
3. Central nervous system cancers: Clinical Practice Guidelines in Oncology. SS Brem PJ Bierman P Black DT Blumenthal H Brem MC Chamberlain EA Chiocca LM DeAngelis RA Fenstermaker HA Fine A Friedman J Glass SA Grossman AB Heimberger L Junck V Levin JJ Loeffler MH Maor A Narayana HB Newton A Olivi J Portnow M Prados J (Pubitemid 44265413)
4. Current management of brain metastases, with a focus on systemic options. CJ Langer MP Mehta, J Clin Oncol 2005 23 6207 6219 10.1200/JCO.2005.03.145 16135488
5. Recursive partitioning analsis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. L Gaspar C Scott M Rotman S Asbell T Phillips T Wasserman WG McKenna R Byhardt, Int J Radiat Oncol Biol Phys 1997 37 745 751 10.1016/S0360-3016(96)00619-0 9128946 (Pubitemid 27181303)
6. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. FJ Lagerwaard PC Levendag PJ Nowak WM Eijkenboom PE Hanssens PI Schmitz, Int J Radiat Oncol Biol Phys 1999 43 795 803 10.1016/S0360-3016(98)00442-8 10098435 (Pubitemid 29152652)
7. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. CA Meyers JA Smith A Bezjak MP Mehta J Liebmann T Illidge I Kunkler JM Caudrelier PD Eisenberg J Meerwaldt R Siemers C Carrie LE Gaspar W Curran SC Phan RA Miller MF Renschler, J Clin Oncol 2004 22 157 165 10.1200/JCO.2004.05.128 14701778 (Pubitemid 41095128)
8. Management of brain metastases. KA Bradley MP Mehta, Semin Oncol 2004 31 693 701 10.1053/j.seminoncol.2004.07.012 15497123 (Pubitemid 39389021)
9. EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. R Soffietti P Cornu JY Delattre R Grant F Graus W Grisold J Heimans J Hildebrand P Hoskin M Kalljo P Krauseneck C Marosi T Siegal C Vecht, Eur J Neurol 2006 13 674 681 10.1111/j.1468-1331.2006.01506.x 16834697 (Pubitemid 44139367)
10. Current management of brain metastases, with a focus on systemic options. CJ Langer MP Mehta, J Clin Oncol 2005 23 6207 6219 10.1200/JCO.2005.03.145 16135488
11. Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow? A Fabi A Vidiri G Ferretti A Felici P Papaldo P Carlini A Mirri C Nuzzo F Cognetti, Cancer Invest 2006 24 466 468 10.1080/07357900600705805 16777702 (Pubitemid 43932692)
12. Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC). F Cappuzzo A Ardizzoni H Soto-Parra C Gridelli P Maione M Tiseo C Calandri S Bartolini A Santoro L Crin Lung Cancer 2003 41 227 231 10.1016/S0169-5002(03) 00189-2 12871787 (Pubitemid 36842787)
13. Non parametric estimation from incomplete observations. EL Kaplan P Meier, J Am Stat Assoc 1958 53 457 481 10.2307/2281868
14. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. D Crivellari O Pagani A Veronesi D Lombardi F Nolè B Thürlimann D Hess M Borner J Bauer G Martinelli R Graffeo C Sessa A Goldhirsch, Ann Oncol 2001 12 353 356 10.1023/A:1011132609055 11332148 (Pubitemid 32288692)
15. Breast cancer with synchronous metastases: trends in survival during a 14-year period. F Andre K Slimane T Bachelot A Dunant M Namer A Barrelier O Kabbaj JP Spano H Marsiglia R Rouzier S Delaloge M Spielmann, J Clin Oncol 2004 22 3302 3308 10.1200/JCO.2004.08.095 15310773 (Pubitemid 41103686)
16. Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. AJ Clayton S Danson S Jolly WD Ryder PA Burt AL Stewart PM Wilkinson RS Welch B Magee G Wilson A Howell AM Wardley, Br J Cancer 2004 91 639 643 15266327 (Pubitemid 39141617)
17. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. JM Varlotto JC Flickinger A Niranjan A Bhatnagar D Kondziolka LD Lunsford, Int J Radiat Oncol Biol Phys 2005 62 1125 1132 10.1016/j.ijrobp.2004.12.092 15990018 (Pubitemid 40884427)
18. Lung cancer - time to move on from chemotherapy. DN Carney, N Engl J Med 2002 346 126 128 10.1056/NEJM200201103460211 11784881 (Pubitemid 34438905)
19. Drug resistance in melanoma: new perspectives. CA La Porta, Curr Med Chem 2007 14 387 391 10.2174/092986707779941078 17305541
20. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology. L Moscetti F Nelli A Felici M Rinaldi S De Santis G D'Auria G Mansueto G Tonini I Sperduti FC Pollera, Cancer 2007 109 274 281 10.1002/cncr.22399 17154161 (Pubitemid 46106242)
21. A randomized trial of surgery in the treatment of single metastases to the brain. RA Patchell PA Tibbs JW Walsh RJ Dempsey Y Maruyama RJ Kryscio WR Markesbery JS Macdonald B Young, N Engl J Med 1990 322 494 500 10.1056/NEJM199002223220802 2405271 (Pubitemid 20067825)
22. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? CJ Vecht H Haaxma-Reiche EM Noordijk GW Padberg JH Voormolen FH Hoekstra JT Tans N Lambooij JA Metsaars AR Wattendorff,, et al. Ann Neurol 1993 33 583 590 10.1002/ana.410330605 8498838 (Pubitemid 23161878)
23. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. H Aoyama H Shirato M Tago K Nakagawa T Toyoda K Hatano M Kenjyo N Oya S Hirota H Shioura E Kunieda T Inomata K Hayakawa N Katoh G Kobashi, JAMA 2006 7 2483 2491 10.1001/jama.295.21.2483 (Pubitemid 43854963)